Pure Biologics S.A. Stock: price and insider trades · Poland
Pure Biologics S.A.: what insiders have been doing
Pure Biologics S.A., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to KNF. Over the twelve months to 7 November 2026, 8 filings were filed, from 1 insider.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Across the 561 companies tracked on its exchange, the median is 3 filings; at 8 filings, this issuer sits above that mark.
Insider buying of Pure Biologics S.A. has been absent for the past year.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Source: insider filings from KNF. Past trades are no guide to future returns.
Financial data
as of FY 2025FY ended December 2025 · cache
- ●Executives0KNF
- ●Executives45,000 PLN0KNF
- ●Executives0KNF
- ●Executives0KNF
- ●Executives0KNF
- ●Executives0KNF
- ●Executives0KNF
- ●Executives0KNF
8 of 8 declarations
About Pure Biologics S.A.
Pure Biologics S.A. is a company focused on the development of innovative biological therapies and pharmaceutical products. It is listed on the XWAR market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
